Bill

Bill > HR6383


US HR6383

US HR6383
Uterine Fibroid Research and Education Act of 2020


summary

Introduced
03/24/2020
In Committee
03/24/2020
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

Uterine Fibroid Research and Education Act of 2020 Uterine Fibroid Research and Education Act of 2020 This bill directs specified components of the Department of Health and Human Services to take certain actions to address uterine fibroids (i.e., muscular tumors that grow in the wall of the uterus and may cause pain, heavy menstrual bleeding, and reproductive issues). Specifically, the National Institutes of Health (NIH), working through the Office of Research on Women's Health, must undertake research activities on uterine fibroids. In carrying out this research, the office must coordinate with specified components of the NIH and other federal agencies. In addition, the Centers for Medicare & Medicaid Services must (1) collect data from Medicaid and the Children's Health Insurance Program about treatment and services related to uterine fibroids, and (2) develop a report in coordination with federal partners on federal and state expenditures for these treatments and services. Additionally, the Centers for Disease Control and Prevention (CDC), the Health Resources Service Administration (HRSA), and the Agency for Healthcare Research and Quality (AHRQ) must disseminate information about uterine fibroids, including the elevated risk for minority women and information regarding available treatments. Specifically, the CDC shall disseminate the information to the public, while HRSA and AHRQ shall disseminate it to health care providers.

AI Summary

This bill directs various components of the Department of Health and Human Services to conduct research, collect data, and disseminate information on uterine fibroids. Specifically, the National Institutes of Health will undertake research activities on uterine fibroids, the Centers for Medicare & Medicaid Services will collect data and develop a report on federal and state expenditures for uterine fibroid treatments, and the Centers for Disease Control and Prevention, the Health Resources Service Administration, and the Agency for Healthcare Research and Quality will disseminate information to the public and health care providers about uterine fibroids, including the elevated risk for minority women and available treatment options.

Committee Categories

Business and Industry

Sponsors (38)

Yvette Clarke (D)* Nanette Barragán (D),  Karen Bass (D),  Sanford Bishop (D),  Anthony Brown (D),  G. Butterfield (D),  Tony Cárdenas (D),  André Carson (D),  Emanuel Cleaver (D),  Jim Clyburn (D),  Danny Davis (D),  Marcia Fudge (D),  Ruben Gallego (D),  Vicente Gonzalez (D),  Raúl Grijalva (D),  Alcee Hastings (D),  Sheila Jackson-Lee (D),  Hakeem Jeffries (D),  Eddie Johnson (D),  Hank Johnson (D),  Robin Kelly (D),  Brenda Lawrence (D),  Barbara Lee (D),  Lucy McBath (D),  Gregory Meeks (D),  Eleanor Holmes Norton (D),  Stacey Plaskett (D),  Ayanna Pressley (D),  Cedric Richmond (D),  Bobby Rush (D),  Michael San Nicolas (D),  David Scott (D),  Terri Sewell (D),  Darren Soto (D),  Bennie Thompson (D),  Dina Titus (D),  Nydia Velázquez (D),  Bonnie Watson Coleman (D), 

Last Action

Referred to the House Committee on Energy and Commerce. (on 03/24/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...